Results 201 to 210 of about 212,546 (262)
Development of Colonic Polyposis in a Woman With Chronic Myeloid Leukemia Treated With Dasatinib. [PDF]
Pelaez G +8 more
europepmc +1 more source
Immunophenotypic changes following menin inhibition in acute myeloid leukemia. [PDF]
Loghavi S +24 more
europepmc +1 more source
CLL-1: An emerging target for immunotherapy in acute myeloid leukemia. [PDF]
Wang Y, Xiao Y.
europepmc +1 more source
A Current Overview of Quality-of-Life Research in Chronic Myeloid Leukemia (CML). [PDF]
Deneberg S.
europepmc +1 more source
Efficacy and safety of FLT3 inhibitors for acute myeloid leukemia: a network meta-analysis. [PDF]
Xu Y, Li J, Gao Y, Huang G, Zeng Y.
europepmc +1 more source
Editorial: Exploiting biomarkers for targeted therapies in acute myeloid leukemia. [PDF]
Carbonell D.
europepmc +1 more source
A Cross‐Organ Symphony of Human Immune System Maturation
Organ Medicine, EarlyView.
Zhan‐Li Chen
wiley +1 more source
Targeting ZMIZ1 induces differentiation in acute myeloid leukemia via chromatin remodeling. [PDF]
Li H +25 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 1999
Over the past twenty years, clinical and laboratory studies have led to important new insights into the biology of chronic myeloid leukemia. Basic science has defined the molecular pathogenesis of chronic myeloid leukemia (CML) as unregulated signal transduction by the Bcr-Abl tyrosine kinase.
Charles Sawyers, Sawyers Charles L
exaly +3 more sources
Over the past twenty years, clinical and laboratory studies have led to important new insights into the biology of chronic myeloid leukemia. Basic science has defined the molecular pathogenesis of chronic myeloid leukemia (CML) as unregulated signal transduction by the Bcr-Abl tyrosine kinase.
Charles Sawyers, Sawyers Charles L
exaly +3 more sources

